Ozempic lowers risk of depression — and not because people are happy they’re thinner
Scientists found that patients taking GLP-1RAs reported fewer symptoms of depression than those on the common diabetes drug dipeptidyl peptidase-4 inhibitors (DPP4is), also known collectively as ...
With drug Empagliflozin going off patent, doctors look forward to price reduction, benefitting diabetic, heart and kidney patients
Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.